Psychiatry Research
Volume 133, Issue 1 , Pages 45-55 , 30 January 2005

Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms

  • Perrine Brazo

      Affiliations

    • Centre Esquirol, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France
    • Groupe d'Imagerie Neurofonctionnelle, UMR 6095, CNRS/CEA/Université de Caen/Université de Paris V, Centre Cyceron, Boulevard Henri Becquerel, 14000 Caen, France
    • Corresponding Author InformationCorresponding author. Centre Esquirol, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France. Tel.: +33 2 31 06 44 28; fax: +33 2 31 06 49 55.
    • ,
  • Pascal Delamillieure

      Affiliations

    • Centre Esquirol, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France
    • Groupe d'Imagerie Neurofonctionnelle, UMR 6095, CNRS/CEA/Université de Caen/Université de Paris V, Centre Cyceron, Boulevard Henri Becquerel, 14000 Caen, France
    • ,
  • Rémy Morello

      Affiliations

    • Département d'Information Médicale, Centre Hospitalier Universitaire (CHU), Avenue Georges Clemenceau, 14033 Caen, France
    • ,
  • Isabelle Halbecq

      Affiliations

    • Centre Esquirol, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France
    • ,
  • Rose-Marie Marié

      Affiliations

    • Service de Neurologie, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France
    • ,
  • Sonia Dollfus

      Affiliations

    • Centre Esquirol, Centre Hospitalier Universitaire (CHU), Avenue Côte de Nacre, 14033 Caen, France
    • Groupe d'Imagerie Neurofonctionnelle, UMR 6095, CNRS/CEA/Université de Caen/Université de Paris V, Centre Cyceron, Boulevard Henri Becquerel, 14000 Caen, France

Received 8 September 2003 ,Accepted 13 October 2004.

References 

  1. Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophrenia Research. 1991;5:123–134
  2. Allen HA, Liddle PF, Frith CD. Negative features, retrieval processes and verbal fluency in schizophrenia. British Journal of Psychiatry. 1993;163:769–775
  3. American Psychiatric Association . DSM IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: Author; 1994;
  4. Ban TA. Drug treatment in schizophrenia. Canadian Psychiatric Association Journal. 1971;16:473–485
  5. Basso MR, Nasrallah HA, Olson SC, Bornstein RA. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research. 1998;31:99–111
  6. Bryson G, Whelahan HA, Bell M. Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Research. 2001;102:29–37
  7. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT. Neuropsychological impairments in deficit vs. nondeficit forms of schizophrenia. Archives of General Psychiatry. 1994;51:804–811
  8. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT. Attentional impairments in deficit and nondeficit forms of schizophrenia. American Journal of Psychiatry. 1997;154:363–370
  9. Bustillo JR, Thaker G, Buchanan RW, Moran M, Kirkpatrick B, Carpenter WT. Visual information-processing impairments in deficit and nondeficit schizophrenia. American Journal of Psychiatry. 1997;154:647–654
  10. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Evocation lexicale formelle et sémantique chez des sujets normaux. Performances et dynamiques de production en fonction du sexe, de l'âge et du niveau d'étude. Acta Neurologica Belgica. 1990;90:207–217
  11. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry. 1988;145:578–583
  12. Chouinard G, Ross-Chouinard A, Annable L, Jones BD. Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Sciences. 1980;7:233
  13. Dollfus S, Ribeyre JM, Petit M. Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms. Psychopathology. 2000;33:125–130
  14. Elvevag B, Weinstock DM, Akil M, Kleinman JE, Goldberg TE. A comparison of verbal fluency tasks in schizophrenic patients and normal controls. Schizophrenia Research. 2001;51:119–126
  15. Foster P. Neuroleptic equivalence. Pharmaceutical Journal. 1989;30:431–432
  16. Frith CD. The cognitive abnormalities underlying the symptomatology and the disability of patients with schizophrenia. International Clinical Psychopharmacology. 1995;10(suppl. 3):87–98
  17. Fuster JM. The Prefrontal Cortex. Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. 3rd ed.. Philadelphia-New York: Lippincott-Raven; 1997;
  18. Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry. 2002;159:983–990
  19. Gerbaldo H, Helisch A, Schneider B, Philipp M, Benkert O. Subtypes of negative symptoms: the primary subtype in schizophrenic and non-schizophrenic patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1994;118:311–320
  20. Glantz SA. Introduction to Biostatistics. New York: McGraw-Hill; 1998;
  21. Golden CJ. In: Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. vol. III:Chigaco: Stoelting Company; 1978;p. 1–32
  22. Hammer MA, Katsanis J, Iacono WG. The relationship between negative symptoms and neuropsychological performance. Biological Psychiatry. 1995;37:828–830
  23. Joyce EM, Collinson SL, Crichton P. Verbal fluency in schizophrenia: relationship with executive function, semantic memory and clinical alogia. Psychological Medicine. 1996;26:39–49
  24. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261–276
  25. Keefe RSE, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophrenia Bulletin. 1999;25:201–222
  26. Kirkpatrick B, Buchanan RW, Alphs LD, McKenney PD, Carpenter WT. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Research. 1989;30:119–123
  27. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT. Depressive symptoms and the deficit syndrome of schizophrenia. Journal of Nervous and Mental Disease. 1994;182(8):452–455
  28. Kirkpatrick B, Amador XF, Yale SA, Bustillo JR, Buchanan RW, Tohen M. The deficit syndrome in the DSM-IV field trial: Part II. Depressive episodes and persecutory beliefs. Schizophrenia Research. 1996;20:79–90
  29. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT. Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biological Psychiatry. 2001;50:453–462
  30. Lafont V, Medecin I, Robert PH, Beaulieu FE, Kazes M, Danion JM, et al. Initiation and supervisory processes in schizophrenia and depression. Schizophrenia Research. 1998;34:49–57
  31. Laplante L, Everett J, Thomas J. Inhibition through negative priming with Stroop stimuli in schizophrenia. British Journal of Clinical Psychology. 1992;31:307–326
  32. Lezak MD. Neuropsychological Assessment. 3rd ed.. New York: Oxford University Press; 1995;
  33. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. British Journal of Psychiatry. 1991;158:340–345
  34. Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin. 1999;25:233–255
  35. Milner B. Effects of different brain lesions on card sorting. Archives of Neurology. 1963;9:100–110
  36. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12:313–324
  37. Peeters E, Jacobs E, Lowyck B, De Hert M, Torfs K, Peuskens J. Trail making data in schizophrenic patients. Schizophrenia Research. 2000;41:291–292
  38. Perret E. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia. 1974;12:323–330
  39. Poole JH, Ober BA, Shenaut GK, Vinogradov S. Independent frontal-system deficits in schizophrenia: cognitive, clinical, and adaptative implications. Psychiatry Research. 1999;85:161–176
  40. Putman KM, Harvey PD. Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophrenia Bulletin. 2000;26(4):867–878
  41. Reitan RM, Wolfson D. The Halstead Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993;
  42. Ribeyre JM, Dollfus S, Lesieur P, Ménard JF, Petit M. Instrument d'évaluation du syndrome déficitaire de la schizophrénie : Schedule for the Deficit Syndrome (SDS) (Kirkpatrick et al.). In: Intérêt et pertinence de la SDS. Présentation de la version française. L'Encéphale. 20:1994;p. 413–419
  43. Robert PH, Migneco V, Marmod D, Chaix I, Thauby S, Benoit M, et al. Verbal fluency in schizophrenia: the role of semantic clustering in category instance generation. European Psychiatry. 1997;12:124–129
  44. Robins LN, Helzer JE, Croughan J, Ratcliff K. National Institute of Mental Health Diagnostic Interview Schedule. Archives of General Psychiatry. 1981;38:381–390
  45. Rossi A, Daneluzzo E, Mattei P, Bustini M, Casacchia M, Stratta P. Wisconsin Card Sorting Test and Stroop Test performances in schizophrenia: a shared construct. Neuroscience Letters. 1997;226:87–90
  46. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustments methods in clinical trials. Statistics in Medicine. 1997;16:2529–2542
  47. Scully PJ, Coakley G, Kinsella A, Waddington JL. Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in ‘static’ v. ‘progressive’ profiles. British Journal of Psychiatry. 1997;171:154–158
  48. Sommers AA. “Negative symptoms”: conceptual and methodological problems. Schizophrenia Bulletin. 1985;11:364–379
  49. Stolar N, Berenbaum H, Banich MT, Barch D. Neuropsychological correlates of alogia and affective flattening in schizophrenia. Biological Psychiatry. 1994;35:164–172
  50. Sweeney JA, Keilp JG, Haas GL, Hill J, Weiden PJ. Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research. 1991;37:297–308
  51. Tek C, Kirkpatrick B, Buchanan RW. A five-year follow-up study of deficit and nondeficit schizophrenia. Schizophrenia Research. 2001;49:253–260
  52. Wagman AMI, Heinrichs DW, Carpenter WT. Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Research. 1987;22:319–330
  53. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Harcourt Brace Jovanovich; 1981;

PII: S0165-1781(04)00251-3

doi: 10.1016/j.psychres.2004.10.001

Psychiatry Research
Volume 133, Issue 1 , Pages 45-55 , 30 January 2005

Article Tools